Skip to content
In deliveryUnited KingdomGoodsFramework agreement£160,000,000

NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives

Published
Published 17 October 2025
Deadline
Closed 6 February 2026

Overview

Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026 Offer reference number: CM/TNS/25/5737 Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£160,000,000
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
17 October 2025
Questions by
30 January 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£160,000,000
Award date
25 February 2026
Contract period
31 March 2026 → 31 March 2028
Winners
  • Abbvie Ltd
  • Gilead Sciences Limited

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    7 April 2026

    View notice ↗
  2. Contract

    26 February 2026

    View notice ↗
  3. Tender Update

    28 January 2026

    View notice ↗
  4. Contract Notice

    22 December 2025

    View notice ↗
  5. Prior Information Notice

    17 October 2025

    View notice ↗

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives — won by Abbvie Ltd +1 — Skim